Our News story 'Drug markers questioned' (Nature 452, 510–511 ; 2008) incorrectly stated that Gleevec (imatinib) has been approved to treat breast cancer. Gleevec is used to treat chronic myeloid leukaemia.
Published online 9 April 2008 | Nature 452, 677 (2008) | doi:10.1038/452677g
Correction
Correction
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
Add your own comment
You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Remember this is for feedback and discussion - not for publishing papers, press releases or advertisements, for example. If you ramble on in an annoying way too often, we may remove your posting privileges.
You need to be registered with Nature to leave a comment. Please log in or register as a new user. You will be re-directed back to this page.
